You have read all your free articles, to continue reading subscribe to read the rest of this content.
Follicum announced on September 17, 2019 that the company had received a Notice of Allowance from the US Patent and Trademark Office regarding the patent application “Novel Compositions and Uses Thereof”. The patent has now formally been granted by the USPTO. The patent is valid until 2032. Already a subscriber…
The company has received the final notice from the Swedish patent Authorities (PRV) for two of its patent applications. ChemoTech is a Swedish medtech company that has developed a technology platform to offer cancer patients who cannot be treated with conventional methods access to a new treatmenAlready a subscriber Login…
Idogen has announced that the Japan Patent Office (“JPO”) has granted the company’s patent application. The patent provides Idogen’s vaccine technology with a broad protection and further strengthens the company’s patent portfolio in an important market. The Japan Patent Office has now Already a subscriber Login You have read all…
The Swedish Patent and Market Court of Appeal has announced its judgment in a case concerning a subcontracting agreement, related to a public procurement of clinical physiology services. The Patent and Market Court of Appeal dismissed the Swedish Competition Authority's request for fines and acquAlready a subscriber Login You have…
